For patients with type 2 diabetes taking semaglutide, understanding how different carbohydrates affect blood glucose remains important despite the medication's glucose-lowering effects
Stretch your expensive medication, dodge nasty side effects, and maintain your weight loss without the full-dose intensity
It says patients with type 2 diabetes may benefit more from tirzepatide's dual mechanism, which activates both GLP-1 and GIP receptors and enhances insulin secretion alongside appetite suppression
In 2021 - 2022, a stronger dose, weekly injectable formulation of Semaglutide (brand name Wegovy) was approved by the US FDA as a medication for weight loss in patients with at least one weight related medical issue
For the first time, we have a drug, semaglutide, that not only causes weight loss, but also reduces the formation of atherosclerotic plaque and prevents deaths and cardiovascular events, says Paola Harwicz, a cardiologist and obesity specialist in Buenos Aires who headed the Cardiometabolism Council of the Argentine Society of Cardiology and participated in the meeting in Philadelphia